Literature DB >> 24760820

Reproducibility issues in science, is P value really the only answer?

Jean Gaudart1, Laetitia Huiart2, Paul J Milligan3, Rodolphe Thiebaut4, Roch Giorgi5.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24760820      PMCID： PMC4024892          DOI： 10.1073/pnas.1323051111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Revised standards for statistical evidence.

Authors:  Valen E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 3.  Clinical trial designs for cytostatic agents: are new approaches needed?

Authors:  E L Korn; S G Arbuck; J M Pluda; R Simon; R S Kaplan; M C Christian
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

4.  Common sense and figures: the rhetoric of validity in medicine (Bradford Hill Memorial Lecture 1999).

Authors:  R Horton
Journal:  Stat Med       Date:  2000-12-15       Impact factor: 2.373

5.  Improving the reporting of randomised trials: the CONSORT Statement and beyond.

Authors:  Douglas G Altman; David Moher; Kenneth F Schulz
Journal:  Stat Med       Date:  2012-08-18       Impact factor: 2.373
  5 in total
  5 in total

1.  Reply to Gelman, Gaudart, Pericchi: More reasons to revise standards for statistical evidence.

Authors:  Valen E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-13       Impact factor: 11.205

2.  P-Mart: Interactive Analysis of Ion Abundance Global Proteomics Data.

Authors:  Lisa M Bramer; Kelly G Stratton; Amanda M White; Ameila H Bleeker; Markus A Kobold; Katrina M Waters; Thomas O Metz; Karin D Rodland; Bobbie-Jo M Webb-Robertson
Journal:  J Proteome Res       Date:  2019-02-06       Impact factor: 4.466

3.  Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure.

Authors:  Stéphanie Boué; Thomas Exner; Samik Ghosh; Vincenzo Belcastro; Joh Dokler; David Page; Akash Boda; Filipe Bonjour; Barry Hardy; Patrick Vanscheeuwijck; Julia Hoeng; Manuel Peitsch
Journal:  F1000Res       Date:  2017-01-05

4.  The earth is flat (p > 0.05): significance thresholds and the crisis of unreplicable research.

Authors:  Valentin Amrhein; Fränzi Korner-Nievergelt; Tobias Roth
Journal:  PeerJ       Date:  2017-07-07       Impact factor: 2.984

Review 5.  Ten Important Considerations for Ovarian Cancer Screening.

Authors:  Edward J Pavlik
Journal:  Diagnostics (Basel)       Date:  2017-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.